Infinium Global Research Preimplantation Genetic Testing Market | Page 2

Infinium Global Research has added a new report on Global Preimplantation Genetic Testing Market. The report predicts the market
size of Preimplantation Genetic Testing is expected to reach XX billion by 2023.
The report on Global Preimplantation Genetic Testing Market provides qualitative and quantitative analysis for the period of 2017 to
2023. According to report the Global Preimplantation Genetic Testing Market is expected to grow at a CAGR between 9.5% and 10.0 %
over the forecast period of 2017 - 2023.
Market Insights:
The report identified that Global Preimplantation Genetic Testing is driven by factors such as growing Public-Private Investments in the
Field of Preimplantation Genetic Testing, Number of Fertility Clinics are increasing worldwide, Decreasing Fertility
Rates, Technological Advancements, and High Risk of Chromosomal Abnormalities With Advancing Maternal Age . While the
restraining factors include High Cost of Preimplantation Genetic Testing and Disapproving Government Regulations . Further, the
report identifies the opportunities in the world market as Improving Healthcare Substructure, Growth Initiatives by Key Market
Players and Developing Medical Tourism .
Get a Sample Report @ https://www.infiniumglobalresearch.com/Reports/MakeSampleRequest/716
Segments Covered
The report on Global Preimplantation Genetic Testing Market covers the segments based on Products and Services, Technology,
Procedure Type, Application and End User . The Products and Services of Preimplantation Genetic Testing include Reagents
and Consumables, Software and Services and Instruments . The technology segment includes Single-Nucleotide Polymorphism,
Next-Generation Sequencing, Fluorescence in Situ Hybridization, Comparative Genomic Hybridization and Polymerase Chain Reaction.
On the basis of Procedure Type the Global Preimplantation Genetic Testing Market is segmented as Preimplantation Genetic
Screening, and Preimplantation Genetic Diagnosis. The Application segment includes Single Gene Disorders, HLA Typing, Structural
Chromosomal Abnormalities, X-Linked Disorders, Aneuploidy and Gender Identification. On the basis of End User Hospitals, Diagnostic
Labs, and Service Providers, Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics.